Author Question: Define acute undifferentiated leukemia and explain why it is difficult to identify. What will be ... (Read 58 times)

stock

  • Hero Member
  • *****
  • Posts: 573
Define acute undifferentiated leukemia and explain why it is difficult to identify.
 
  What will be an ideal response?

Question 2

A technologist is reviewing a blood smear and notices 35 lymphocytes with azurophilic granules and nuclei with mature clumped chromatin. These cells are typical of those found in:
 
  a. Hairy cell leukemia
  b. Szary syndrome
  c. Large granular lymphocyte leukemia
  d. Chronic prolymphocytic leukemia



pallen55

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

Answer: Acute undifferentiated leukemias is an acute leukemia in which the morphology, cytochemistry, and immunophenotype of the proliferating blasts lack sufficient information to classify them as myeloid or lymphoid origin. They are difficult to identify by conventional methods because they share common detectable markers of multiple lineages.

Answer to Question 2

Correct Answer: C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Dogs have been used in studies to detect various cancers in human subjects. They have been trained to sniff breath samples from humans that were collected by having them breathe into special tubes. These people included 55 lung cancer patients, 31 breast cancer patients, and 83 cancer-free patients. The dogs detected 54 of the 55 lung cancer patients as having cancer, detected 28 of the 31 breast cancer patients, and gave only three false-positive results (detecting cancer in people who didn't have it).

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library